Tune in September 10th, 8PM ET/PT to watch on Vh1.
In the fifth of five in SU2C's Dream Team series, team leaders Slamon and Gray talk about the science behind their project, which focuses on breast cancer subtypes.
In the third of five in SU2C's Dream Team series, Epigenetics Team Leaders Baylin and Jones talk about the science behind their project, focusing on bringing epigenetics to the forefront of cancer management.
Stand Up To Cancer Dream Team leaders define Personal Medicine and describe how it can help scientists battle cancer more effectively.
In the first of five in SU2C's Dream Team series, Pancreatic Cancer Team Leaders Von Hoff and Thompson talk about the science behind their project.
Stand Up To Cancer PI3K Dream Team scientists explain their progress over the last year and look towards the future.
Stand Up To Cancer's Dream Team of Scientists define translational research and talk about why it is so important to cancer patients.
SU2C's Innovative Research Grants support risky, cutting-edge research with the potential to strongly impact patient care.
Musicians rehearse for the Stand Up to Cancer 2010 Big Show.
Stand Up To Cancer Epigenetics Dream Team scientists explain their progress over the last year and look towards the future.
See why innovative research is so important in the fight against cancer and find out how Stand Up To Cancer's Innovative Research Grants are bringing together the brightest young minds for new hope in cancer research and patient care.
Stand Up to Cancer Breast Cancer Dream Team scientists explain their progress over the last year and look towards the future.
Stand Up To Cancer Dream Team leaders define Interdisciplinary Research and describe how it can help scientists work together as they battle cancer more effectively.
Learn about the exciting science behind SU2C's 2011 Innovative Research Grant recipients, and how each recipient will focus on cutting-edge research that has the potential to strongly impact patient care.
SU2C Dream Team scientists come together in Miami to share their team's early progress and discuss opportunities to collaborate with one another and bring us closer to the end of cancer.